Showing results (31-40 of 233) with videos related to
Sort By:
Pageof 24
Expert Opinion on Biological Therapy|July 31, 2019
Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatmentMaëlle le Besnerais, Agnès Veyradier, Ygal Benhamou, et al.Methods in Molecular Biology (Clifton, N.J.)|March 31, 2026
Treating Immune-Mediated Thrombotic Thrombocytopenic Purpura with CaplacizumabJúlia Weisinger, Bérangère S Joly, Agnès Veyradier, et al.Stroke|March 7, 2025
Thrombotic Thrombocytopenic Purpura: A Missed Cause in Stroke Prevention GuidelinesAdrien Picod, Bérangère S Joly, Agnès Veyradier, et al.Blood|July 3, 2024
Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndromeSpero R Cataland, Paul Coppo, Marie Scully, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomesAdrien Joseph, Stéphanie Harel, Laurent Mesnard, et al.Journal of Internal Medicine|August 4, 2023
Thrombotic microangiopathy associated with anticancer and immune system targeting drugs: New insights from real-world data using the WHO pharmacovigilance databaseBérenger Largeau, Benjamin Thoreau, Steven Grangé, et al.European Journal of Internal Medicine|June 27, 2021
Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMANihal Martis, Matthieu Jamme, Corinne Bagnis-Isnard, et al.Pediatrics|June 1, 2017
Life-Threatening Pneumopathy and U urealyticum in a STAT3-Deficient Hyper-IgE Syndrome PatientGuillaume Deverrière, Ludovic Lemée, Steven Grangé, et al.Cellular Signalling|October 7, 2008
BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levelsPaul Coppo, Isabelle Dusanter-Fourt, William Vainchenker, et al.Clinical Case Reports|December 30, 2022
Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B-cell lymphomaMatthieu Delaye, Laure Ricard, Lucas Maisonobe, et al.Pageof 24